CN111378788A - 辅助covid-19诊断的菌种标志物及其应用 - Google Patents
辅助covid-19诊断的菌种标志物及其应用 Download PDFInfo
- Publication number
- CN111378788A CN111378788A CN202010269684.0A CN202010269684A CN111378788A CN 111378788 A CN111378788 A CN 111378788A CN 202010269684 A CN202010269684 A CN 202010269684A CN 111378788 A CN111378788 A CN 111378788A
- Authority
- CN
- China
- Prior art keywords
- strain
- covid
- prevotella
- marker
- diagnosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000025721 COVID-19 Diseases 0.000 title claims abstract description 56
- 239000003550 marker Substances 0.000 title claims abstract description 40
- 238000003745 diagnosis Methods 0.000 title claims abstract description 26
- 230000001580 bacterial effect Effects 0.000 title claims description 22
- 238000001514 detection method Methods 0.000 claims abstract description 47
- 206010035664 Pneumonia Diseases 0.000 claims abstract description 46
- 241000186429 Propionibacterium Species 0.000 claims abstract description 15
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 15
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 15
- 241000605861 Prevotella Species 0.000 claims abstract description 14
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 14
- 241000606766 Haemophilus parainfluenzae Species 0.000 claims abstract description 10
- 244000000010 microbial pathogen Species 0.000 claims abstract description 10
- 241000605909 Fusobacterium Species 0.000 claims abstract description 9
- 208000015181 infectious disease Diseases 0.000 claims abstract description 8
- 241000589876 Campylobacter Species 0.000 claims abstract description 5
- 241000605862 Porphyromonas gingivalis Species 0.000 claims abstract description 4
- 241000894007 species Species 0.000 claims description 26
- 238000004458 analytical method Methods 0.000 claims description 22
- 239000000523 sample Substances 0.000 claims description 19
- 238000012163 sequencing technique Methods 0.000 claims description 14
- 241001148134 Veillonella Species 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 241001533207 Veillonella atypica Species 0.000 claims description 5
- 206010036790 Productive cough Diseases 0.000 claims description 4
- 239000012472 biological sample Substances 0.000 claims description 4
- 208000024794 sputum Diseases 0.000 claims description 4
- 210000003802 sputum Anatomy 0.000 claims description 4
- 241000606806 Aggregatibacter segnis Species 0.000 claims description 3
- 241000605894 Porphyromonas Species 0.000 claims description 2
- 238000003766 bioinformatics method Methods 0.000 claims description 2
- 230000002068 genetic effect Effects 0.000 claims description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 208000037847 SARS-CoV-2-infection Diseases 0.000 abstract description 8
- 241000700605 Viruses Species 0.000 abstract description 5
- 230000007547 defect Effects 0.000 abstract description 4
- 241000605986 Fusobacterium nucleatum Species 0.000 abstract description 2
- 241000606790 Haemophilus Species 0.000 abstract description 2
- 241000606822 Haemophilus parahaemolyticus Species 0.000 abstract description 2
- 241001135221 Prevotella intermedia Species 0.000 abstract description 2
- 241000606788 Haemophilus haemolyticus Species 0.000 abstract 1
- 230000003239 periodontal effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 210000002345 respiratory system Anatomy 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 238000001914 filtration Methods 0.000 description 8
- 238000012216 screening Methods 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 241001678559 COVID-19 virus Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000010606 normalization Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000012795 verification Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012165 high-throughput sequencing Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 206010024971 Lower respiratory tract infections Diseases 0.000 description 2
- 206010035737 Pneumonia viral Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000007621 cluster analysis Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000012821 model calculation Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 208000009421 viral pneumonia Diseases 0.000 description 2
- 241000186046 Actinomyces Species 0.000 description 1
- 241001288806 Alloprevotella tannerae Species 0.000 description 1
- 201000001178 Bacterial Pneumonia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000605059 Bacteroidetes Species 0.000 description 1
- 206010061695 Biliary tract infection Diseases 0.000 description 1
- 241000589992 Campylobacter showae Species 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241001339048 Fusobacterium hwasookii Species 0.000 description 1
- 241000605994 Fusobacterium periodonticum Species 0.000 description 1
- 241001657446 Gemella sanguinis Species 0.000 description 1
- 241000819598 Haemophilus sputorum Species 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 206010025080 Lung consolidation Diseases 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- -1 NGS nucleic acid Chemical class 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- 241000782070 Prevotella multiformis Species 0.000 description 1
- 241001365165 Prevotella nanceiensis Species 0.000 description 1
- 241001135225 Prevotella nigrescens Species 0.000 description 1
- 241000530934 Prevotella timonensis Species 0.000 description 1
- 241000192142 Proteobacteria Species 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 238000001772 Wald test Methods 0.000 description 1
- 241001659030 [Propionibacterium] humerusii Species 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000001254 matrix assisted laser desorption--ionisation time-of-flight mass spectrum Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000013102 re-test Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000011425 standardization method Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
菌种名称 | P-Value | FDR | Lo2(Fold change) |
Aggregatibacter_segnis | 0.002716738 | 0.041189256 | -3.810811251 |
Alloprevotella_tannerae | 0.001265617 | 0.023780636 | -3.817815723 |
Campylobacter_showae | 0.003399851 | 0.044386946 | -4.667353991 |
Fusobacterium_hwasookii | 0.001315525 | 0.023780636 | -4.139240994 |
Fusobacterium_nucleatum | 0.000537826 | 0.018055582 | -4.951794732 |
Fusobacterium_periodonticum | 0.000894371 | 0.020016869 | -5.019757987 |
Gemella_sanguinis | 0.000808839 | 0.020016869 | -4.682127973 |
Haemophilus_parahaemolyticus | 0.000197715 | 0.011615733 | -6.366137313 |
Haemophilus_parainfluenzae | 0.000519635 | 0.018055582 | -3.635019117 |
Haemophilus_sputorum | 3.12E-05 | 0.004886593 | -7.823944276 |
Porphyromonas_gingivalis | 1.40E-05 | 0.003300893 | -5.877449378 |
Prevotella_intermedia | 0.000390556 | 0.01529677 | -4.379586386 |
Prevotella_multiformis | 9.65E-05 | 0.007561098 | -6.645933162 |
Prevotella_nanceiensis | 1.18E-07 | 5.54E-05 | -6.961019486 |
Prevotella_nigrescens | 0.000974162 | 0.020811637 | -5.381729756 |
Prevotella_timonensis | 0.001148838 | 0.023476257 | -2.743454942 |
Propionibacterium_humerusii | 0.001258502 | 0.023780636 | -1.082820347 |
Veillonella_atypica | 0.000749859 | 0.020016869 | -4.646543908 |
ID | AUC |
菌种1 | 0.789377289 |
菌种2 | 0.833333333 |
菌种3 | 0.84981685 |
菌种1+菌种2 | 0.857142857 |
菌种1+菌种3 | 0.860805861 |
菌种2+菌种3 | 0.904761905 |
菌种1+菌种2+菌种3 | 0.91025641 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010269684.0A CN111378788B (zh) | 2020-04-08 | 2020-04-08 | 辅助covid-19诊断的菌种标志物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010269684.0A CN111378788B (zh) | 2020-04-08 | 2020-04-08 | 辅助covid-19诊断的菌种标志物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111378788A true CN111378788A (zh) | 2020-07-07 |
CN111378788B CN111378788B (zh) | 2021-02-26 |
Family
ID=71215655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010269684.0A Active CN111378788B (zh) | 2020-04-08 | 2020-04-08 | 辅助covid-19诊断的菌种标志物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111378788B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112067712A (zh) * | 2020-08-18 | 2020-12-11 | 上海纳米技术及应用国家工程研究中心有限公司 | 一种诊断新型冠状病毒的挥发性标志物及其应用 |
CN112309499A (zh) * | 2020-11-09 | 2021-02-02 | 浙江大学 | 一种细菌pdif快速注释方法及装置 |
CN112609024A (zh) * | 2020-12-31 | 2021-04-06 | 郑州大学第一附属医院 | 一种用于新型冠状病毒感染患者无创诊断的肠道微生物基因标志物及其应用 |
CN112798678A (zh) * | 2021-03-22 | 2021-05-14 | 中国疾病预防控制中心传染病预防控制所 | 基于血清的新型冠状病毒感染快速检测方法 |
CN113308560A (zh) * | 2020-12-31 | 2021-08-27 | 郑州大学第一附属医院 | 一种用于新型冠状病毒感染患者无创诊断的口腔微生物基因标志物及其应用 |
CN113488107A (zh) * | 2021-07-07 | 2021-10-08 | 广州华银健康医疗集团股份有限公司 | 筛选免疫组库测序生物标志物的方法、设备和存储介质 |
CN114703305A (zh) * | 2022-04-11 | 2022-07-05 | 郑州大学第一附属医院 | 用于预测新冠肺炎患者一年后中和抗体水平的口腔微生物基因标志物及其应用 |
WO2022166487A1 (zh) * | 2021-02-04 | 2022-08-11 | 北京毅新博创生物科技有限公司 | 特征多肽组合物及质谱模型用于制备新冠肺炎检测产品的用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104540962A (zh) * | 2012-08-01 | 2015-04-22 | 深圳华大基因研究院 | 糖尿病生物标志物及其应用 |
-
2020
- 2020-04-08 CN CN202010269684.0A patent/CN111378788B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104540962A (zh) * | 2012-08-01 | 2015-04-22 | 深圳华大基因研究院 | 糖尿病生物标志物及其应用 |
Non-Patent Citations (2)
Title |
---|
ROBERT P. DICKSON等: "The Role of the Microbiome in Exacerbations of Chronic Lung Diseases", 《LANCET》 * |
李宗杰 等: "肺部菌群与呼吸道疾病的相互关系", 《生物技术通报》 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112067712A (zh) * | 2020-08-18 | 2020-12-11 | 上海纳米技术及应用国家工程研究中心有限公司 | 一种诊断新型冠状病毒的挥发性标志物及其应用 |
CN112309499A (zh) * | 2020-11-09 | 2021-02-02 | 浙江大学 | 一种细菌pdif快速注释方法及装置 |
CN112609024A (zh) * | 2020-12-31 | 2021-04-06 | 郑州大学第一附属医院 | 一种用于新型冠状病毒感染患者无创诊断的肠道微生物基因标志物及其应用 |
CN113308560A (zh) * | 2020-12-31 | 2021-08-27 | 郑州大学第一附属医院 | 一种用于新型冠状病毒感染患者无创诊断的口腔微生物基因标志物及其应用 |
CN113308560B (zh) * | 2020-12-31 | 2023-07-07 | 郑州大学第一附属医院 | 一种用于新型冠状病毒感染患者无创诊断的口腔微生物基因标志物及其应用 |
CN112609024B (zh) * | 2020-12-31 | 2023-08-15 | 郑州大学第一附属医院 | 一种用于新型冠状病毒感染患者无创诊断的肠道微生物基因标志物及其应用 |
WO2022166487A1 (zh) * | 2021-02-04 | 2022-08-11 | 北京毅新博创生物科技有限公司 | 特征多肽组合物及质谱模型用于制备新冠肺炎检测产品的用途 |
CN112798678A (zh) * | 2021-03-22 | 2021-05-14 | 中国疾病预防控制中心传染病预防控制所 | 基于血清的新型冠状病毒感染快速检测方法 |
CN113488107A (zh) * | 2021-07-07 | 2021-10-08 | 广州华银健康医疗集团股份有限公司 | 筛选免疫组库测序生物标志物的方法、设备和存储介质 |
CN113488107B (zh) * | 2021-07-07 | 2022-07-19 | 广州华银康医疗集团股份有限公司 | 筛选免疫组库测序生物标志物的方法、设备和存储介质 |
CN114703305A (zh) * | 2022-04-11 | 2022-07-05 | 郑州大学第一附属医院 | 用于预测新冠肺炎患者一年后中和抗体水平的口腔微生物基因标志物及其应用 |
CN114703305B (zh) * | 2022-04-11 | 2023-07-07 | 郑州大学第一附属医院 | 用于预测新冠肺炎患者一年后中和抗体水平的口腔微生物基因标志物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN111378788B (zh) | 2021-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111378788B (zh) | 辅助covid-19诊断的菌种标志物及其应用 | |
CN111041089B (zh) | Covid-19感染的宿主标志物的应用 | |
US20120114661A1 (en) | Methods of identifying infectious disease and assays for identifying infectious disease | |
CN113223618B (zh) | 基于宏基因组的临床重要致病菌毒力基因检测的方法及系统 | |
CN110904213B (zh) | 一种基于肠道菌群的溃疡性结肠炎生物标志物及其应用 | |
US20240201186A1 (en) | Triage biomarkers and use therefor | |
CN116171198A (zh) | 用于快速早期检测感染的宿主rna生物标志物和早期鉴定人的covid-19冠状病毒感染的系统、方法和组合物 | |
WO2019001187A1 (zh) | 一种快速区分五种小鼠呼吸道病原的多重液相基因芯片检测引物、试剂盒及方法 | |
CN111647673A (zh) | 微生物菌群在急性胰腺炎中的应用 | |
CN116656851B (zh) | 一种生物标志物及其在慢性阻塞性肺疾病诊断方面的应用 | |
CN114381509A (zh) | 与非结核性肺炎有关的血浆miRNA标志物及其应用 | |
CN110408630B (zh) | 结核分枝杆菌H37Rv编码基因及其应用 | |
CN108384782B (zh) | 检测引发血流感染病原体的成套试剂和试剂盒 | |
CN106011154A (zh) | 一种致肝脓肿肺炎克雷伯菌分子检测试剂盒及其应用 | |
CN114214438B (zh) | 胆道菌群检测试剂在制备预测胆道结石术后早期复发的试剂中的应用 | |
CN112011605B (zh) | 微生物菌群在疾病诊断中的应用 | |
WO2023021978A1 (ja) | 自己免疫疾患を検査する方法 | |
CN112063709B (zh) | 一种以微生物作为诊断标志物的重症肌无力的诊断试剂盒及应用 | |
Qin et al. | Combined use of real-time PCR and nested sequence-based typing in survey of human Legionella infection | |
CN114657270A (zh) | 一种基于肠道菌群的阿尔茨海默病生物标志物及其应用 | |
CN116068193B (zh) | 结核病分子标志物组合及其用途 | |
CN112029880B (zh) | 用于重症肌无力的检测的微生物及应用 | |
CN114839369B (zh) | 急性高原反应微生物标志物及其应用 | |
CN111996248B (zh) | 检测微生物的试剂及其在重症肌无力诊断中的应用 | |
WO2024092963A1 (zh) | 一种基于肠道菌群的阿尔茨海默病生物标志物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201010 Address after: 510130 No. 301, building G10, South China new material innovation park, self compiled building 3, No. 31, Kefeng Road, Guangzhou high tech Industrial Development Zone, Guangdong Province Applicant after: Guangzhou Weiyuan Medical Equipment Co.,Ltd. Applicant after: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd. Applicant after: Guangzhou Weiyuan medical laboratory Co.,Ltd. Applicant after: Shenzhen Weiyuan Medical Technology Co.,Ltd. Applicant after: Weiyuan (Shenzhen) Medical Research Center Co.,Ltd. Address before: 510130 Three South China New Materials Innovation Park G10 Building 303, No. 31 Kefeng Road, Guangzhou High-tech Industrial Development Zone, Guangdong Province Applicant before: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd. Applicant before: Guangzhou Weiyuan Medical Equipment Co.,Ltd. Applicant before: Guangzhou Weiyuan medical laboratory Co.,Ltd. Applicant before: Shenzhen Weiyuan Medical Technology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Bacterial markers for covid-19 diagnosis and their application Effective date of registration: 20220424 Granted publication date: 20210226 Pledgee: Bank of China Limited Guangzhou Development Zone Branch Pledgor: Guangzhou Weiyuan Medical Equipment Co.,Ltd.|GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd.|Guangzhou Weiyuan medical laboratory Co.,Ltd.|Shenzhen Weiyuan Medical Technology Co.,Ltd.|Weiyuan (Shenzhen) Medical Research Center Co.,Ltd. Registration number: Y2022980004742 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230509 Granted publication date: 20210226 Pledgee: Bank of China Limited Guangzhou Development Zone Branch Pledgor: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd.|Guangzhou Weiyuan Medical Equipment Co.,Ltd.|Guangzhou Weiyuan medical laboratory Co.,Ltd.|Shenzhen Weiyuan Medical Technology Co.,Ltd.|Weiyuan (Shenzhen) Medical Research Center Co.,Ltd. Registration number: Y2022980004742 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Bacterial biomarkers for assisting COVID-19 diagnosis and their applications Effective date of registration: 20230510 Granted publication date: 20210226 Pledgee: Bank of China Limited Guangzhou Development Zone Branch Pledgor: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd.|Guangzhou Weiyuan Medical Equipment Co.,Ltd.|Guangzhou Weiyuan medical laboratory Co.,Ltd.|Shenzhen Weiyuan Medical Technology Co.,Ltd.|Weiyuan (Shenzhen) Medical Research Center Co.,Ltd. Registration number: Y2023980040254 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20210226 Pledgee: Bank of China Limited Guangzhou Development Zone Branch Pledgor: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd.|Guangzhou Weiyuan Medical Equipment Co.,Ltd.|Guangzhou Weiyuan medical laboratory Co.,Ltd.|Shenzhen Weiyuan Medical Technology Co.,Ltd.|Weiyuan (Shenzhen) Medical Research Center Co.,Ltd. Registration number: Y2023980040254 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Bacterial biomarkers for assisting COVID-19 diagnosis and their applications Granted publication date: 20210226 Pledgee: Bank of China Limited Guangzhou Development Zone Branch Pledgor: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd.|Guangzhou Weiyuan Medical Equipment Co.,Ltd.|Guangzhou Weiyuan medical laboratory Co.,Ltd.|Shenzhen Weiyuan Medical Technology Co.,Ltd.|Weiyuan (Shenzhen) Medical Research Center Co.,Ltd. Registration number: Y2024980019292 |